参考文献/References:
[1]SMITH P S, PENA M, DZUBA I G, et al Safety,efficiency and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City [J]. Reproductive Health Matters, 2015, 22(44): 75-82.
[2]RAYMOND E G, SHANNON C, WEAVER M A, et al. First-trimester medical abortion with mifepristone 200mg and misoprostol:a systematic review [J]. Contraception, 2013, 87(1): 26-37.
[3]BRACKEN H, DABASH R, TSERTSVADZE G, et al. A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial [J]. Contraception, 2014, 89(3): 181-186.
[4]韩敏.药物流产后加服米索前列醇对流产结局影响的临床分析 [J].中国计划生育和妇产科,2010,2(1):25-27.
[5]CLELAND K, CREININ M D, NUCATOLA D, et al. Significant adverse events and outcomes after medical abortion [J]. Obstetrics and Gynecology, 2013, 121(1): 166-171.
[6]何淑明,梁丽霞,黄惠芳,等.仿生物电刺激治疗卵巢储备功能下降患者的疗效 [J].广东医学,2013,34(12):1851-1855.
[7]Madafeitom MA, Bodombosou-Djobo, Chengyu Zheng,et al. Neruomuscular electrical stimulation and biofeedback therapy may improve endometrial growth for patients with thin endometrium during frozen-thawed embryo transfer :A preliminary report [J].Reprod Biol Endocrinol,2011,9(1):122.
[8]朱迎.屈螺酮炔雌醇的非避孕临床应用 [J].国际妇产科学杂志,2011,38(3):231-233, 240.
[9]朱慧玲,程利南.药物流产后阴道出血的原因分析和治疗现状 [J].中国计划生育学杂志,2006,14(9):569-571.
[10]KERNS J, STEINAUER J. Management of postabortion hemorrhage: release date November 2012 SFP Guideline 20131 [J]. Contraception, 2013, 87(3): 331-342.
相似文献/References:
[1]刘义.生化汤配合催产素治疗药物流产后出血的观察[J].中国计划生育和妇产科,2009,(05):0.
[2]王立.药物流产后阴道持续出血清宫时机选择——附74例分析[J].中国计划生育和妇产科,2009,(06):0.
WANG Li The peoples hospital of Henggang region,Shenzhen city,Shenzhen Guangdong 8,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(7):0.
[3]韩敏.药物流产后加服米索前列醇对流产结局影响的临床分析[J].中国计划生育和妇产科,2010,(01):0.
HAN Min Family planning service station of Donghai county,Lianyungang city,Lianyungang Jiangsu 00,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(7):0.
[4]何晓燕,陈德萍.米非司酮配伍米索前列醇不同给药途径终止10~13周妊娠临床观察[J].中国计划生育和妇产科,2010,(03):0.
HE Xiao-yan,CHEN De-ping ..[J].Chinese Journal of Family Planning & Gynecotokology,2010,(7):0.
[5]赵芳,秦翔娟,薛琦霞,等.戊酸雌二醇配伍米索前列醇在稽留流产中的应用价值[J].中国计划生育和妇产科,2014,(04):0.
ZHAO Fang,QIN Xiang-juan,XUE Qi-xia,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(7):0.
[6]柯梅英,岑秋妹,冯亦芳,等.药物与人工流产终止早期妊娠的临床比较[J].中国计划生育和妇产科,2014,(04):0.
KE Mei-ying,CEN Qiu-mei,FENG Yi-fang,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(7):0.
[7]王桂芳,刘蓓,张昀,等.康妇炎胶囊联合益母草用于药物流产术后治疗的临床研究[J].中国计划生育和妇产科,2015,(07):0.
WANG Gui-fang,LIU Bei,ZHANG Yun,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(7):0.
[8]季晓黎,唐诗韵.桂枝茯苓丸防治米非司酮配伍米索前列醇药物流产后阴道出血的系统评价[J].中国计划生育和妇产科,2015,(09):0.
JI Xiao-li,TANG Shi-yun,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(7):0.
[9]梅玲*,潘小玲.药物流产后子宫动脉假性动脉瘤形成1例[J].中国计划生育和妇产科,2019,(9):21.